Physician profile
Nadia Ansari
NPI 1477858827
$1,742.75
in general payments reported to CMS, 2019-2025
18 companies · $273 in 2025
The $273 reported for 2025 was more than what 82% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $186 · 2021: $216 · 2022: $237 · 2023: $333 · 2024: $327 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $932.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $932.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $412.91 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Pfizer INC. | $411.56 | 2019-2024 | |
| Cranial Technologies, INC | $334.27 | 2019-2025 | Doc Band |
| Sanofi Pasteur INC. | $141.96 | 2021-2024 | |
| Corium, LLC | $88.81 | 2024 | Azstarys |
| Amgen INC. | $78.76 | 2025 | |
| Kaleo, INC. | $39.94 | 2022 | |
| Seqirus USA INC | $34.76 | 2024-2025 | Flucelvax, Fluad |
| Ars Pharmaceuticals Operations, INC. | $32.73 | 2025 | Neffy |
| Cognoa, INC. | $24.97 | 2022 | |
| Ironshore Pharmaceuticals INC. | $24.32 | 2023 | Jornay Pm |
| Insulet Corporation | $21.64 | 2024 | Omnipod |
| Supernus Pharmaceuticals, INC. | $19.48 | 2025 | Qelbree |
| Sobi, INC | $16.42 | 2019 | |
| Neos Therapeutics, LP | $15.76 | 2025 | Cotempla Xr-Odt |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $15.11 | 2025 | Valtoco |
| Astrazeneca Pharmaceuticals LP | $14.88 | 2021 | |
| Phadia US INC. | $14.47 | 2023 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nadia Ansari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.